Ideas

Ideas

2019 Year in Review
Reaching the Last Mile
In a year like no other, an opportunity to give like never before
Looking back at COVID-19 in 2020: A Q&A with Hari Menon
Looking back at COVID-19 in 2020: A Q&A with Oumar Seydi
Work in progress: An update on our DEI journey
3 ways advances in disease modeling will help end malaria
“Changing what impossible means” in Sierra Leone through innovation
One year in: Extraordinary achievement, powerful momentum, and still a shortfall for the ACT-Accelerator
How do you solve a problem like malaria?
Insights from AIDS 2018
How these Grand Challenge winners are helping to make every student a “math person”
With a dash of banana-flavoring, the antibiotic azithromycin can be a remedy to childhood mortality
The fight against antimicrobial resistance
Data show why we must be cautiously optimistic about reaching the UN’s Sustainable Development Goal
Solving crowded hospitals and inadequate maternal care are keys for reducing infant mortality
Sophisticated new maps chart the geography of childhood malnutrition in Africa
Under the microscope: Learning more about childhood mortality
Adapting to climate change
The Collaboratory: How sharing tools and technologies can shorten the timeline for global health R&D
Students and families deserve more information about the value of college
Code vs. COVID-19
How to help students get to college in the COVID era
After low-income women lose their jobs in the COVID-19 economy, what happens to them?
Why we're giving $250 million more to fight COVID-19
When a COVID-19 vaccine is ready, this group will make sure the whole world can access it
A down payment on a COVID-free future
The Rebuilders: Goalkeepers constructing the post-pandemic world
Using authentic voices and stories to upend views on poverty and race
Combating COVID-19 in India
Schools and students during the COVID-19 outbreak in America: A conversation with Allan Golston
The strangest school year in memory is about to end. How do we get ready for the next one?
“Seattle isn’t just our headquarters. It’s our home”: A conversation with Amy Carter about BMGF’s local response to a global pandemic
What it will take to make self-administered COVID-19 testing possible
Polio teams respond to COVID-19: A conversation with Dr. Erin Stuckey
ReFRAMing Research: How new technology could reveal a treatment for COVID-19
Pandemic Philanthropy: A Q&A with Caira Woods about how nonprofits are handling the high demand for, and supply of, charitable giving
Potential plasma treatments for COVID-19: A conversation with Dr. Toni Hoover
Developing COVID-19 therapeutics: An investment that needs to happen
Three weeks, two drug trials: An update on the Therapeutics Accelerator with Trevor Mundel
The African Footprint: How the continent's preparedness impacts the rest of the world
Giving in the time of COVID-19: A conversation with Victoria Vrana about the new PowerOf platform
Primary health care is exactly that
Humanizing quantitative data: A Q&A with Chloé Roubert and Micki Semler
Our COVID-19 response: Q&A with Mark Suzman
Fighting COVID-19 globally—and specifically
Twenty years in the making: The foundation’s response to COVID-19
Announcing the COVID-19 Therapeutics Accelerator
COVID-19: How you can help from home
Our approach to COVID-19 in Africa with Oumar Seydi
Africa: In the fight against COVID-19, an unsung  continent
A conversation with Trevor Mundel: Ensuring affordable COVID-19 vaccine doses reach low-and middle-income countries
“We’re preparing for 2021 today”: An update on the Therapeutics Accelerator
A COVID-19 vaccine might be ready within 18 months. But what happens then?
Why we focus on vaccine equity
A three-part plan to eliminate COVID-19
Four reasons why this week was a turning point in the fight against COVID-19
Assessing the news about COVID-19 vaccines: A Q&A with Dr. Lynda Stuart
How a virologist named Ruth saved millions of children and led Bill & me to get into philanthropy
The pandemic is forcing us all online. Can self-help and savings groups for low-income women go digital, too?
During COVID-19, women’s health care must be an essential service: A conversation with three experts
With vaccine deliveries to Accra and Abidjan, the race for equity begins
Heeding lessons from India’s second wave
Put women at the heart of the economic recovery
As COVID-19 cases surge, African institutions lead response efforts
Gates Foundation COVID-19 Response FAQ
Sharing COVID-19 vaccines can help save lives
Making diversity, equity, and inclusion part of everything we do
Seeking diversity? Avoid these common traps
The Democratic Republic of Congo just stopped a killer disease in its tracks. What's next?
For Black and Latino students, and students experiencing poverty, mastering Algebra 1 is the X-Factor
Why Black colleges and universities are America’s newest–and most critical–diagnostic testing hubs
How Emergency Operations Centers are aiding the COVID-19 response
An extraordinary response at an extraordinary moment
Time to go big: Promoting an equitable economic recovery
Stories of Progress: Goalkeepers 2019
Exemplars in Global Health: Q&A with Dr. Niranjan Bose
Nothing for young people, without young people: Making family planning access youth-centered
“Slow” fashion brings fast progress to healthcare in Bihar, India
Five years makes a difference
Doubling down on food fortification to fortify the future
The foundation launches its new website
Moving forward
Keeping vaccination goals close, no matter how afar
How a revolutionary vaccine “blew away” Meningitis A outbreaks in Burkina Faso
What if we could make every woman and girl count?
Prioritizing gender equality can help us build back stronger from COVID-19. Here’s how.
Gender equality. No, there isn't an app for that
Poverty is sexist: A Q&A with new Gender Equality Division President Anita Zaidi
Gene therapy for global health: A Q&A with Dr. Mike McCune
Getting a Grip on Malaria
Malaria in den Griff Bekommen
Does the toilet need reinventing?
Muss die Toilette neu erfunden werden?
The vital importance of everyday giving: A Q&A with Bill and Melinda Gates
A world of giving
Worldwide in scope, but local in relevance, the Global Burden of Disease report is revolutionizing health surveillance
Global partners respond to new Ebola outbreak
Global action to end the COVID-19 crisis
Which targets should Goalkeepers focus on?
Giving young people the best future we can
The demographic dividend and youth in sub-Saharan Africa
Technology and trust: Investing in youth to accelerate economic progress
News – and not the fake kind – is holding back the SDGs
Their future, our goal: The case for investing in adolescents
Good news: Guinea worm disease is on the verge of eradication
Supporting locally led innovation in global health and development
Why we invest in innovation
Has the fight against polio been worth it?
Measuring the value of health
COVID-19 is showing us how to improve health systems—sometimes by disrupting them
Too expensive, too slow, too discriminatory, and other myths about the polio eradication program
Health workers in Nigeria are using lessons learned from polio to fight the Lassa fever outbreak
How investments in HIV prevention could help build a healthier future for women
Overcoming fear and stigma in the age of HIV/AIDS
How do you decide what to invest in?
India announces plan to end tuberculosis by 2025
Further together: Insights from our India country office
With national gains in health, the women polo players of Manipur, India, take their shot
Learning to innovate during global emergencies
Governments build roads and bridges. Why is another essential piece of infrastructure, child care, built on women’s unpaid labor?
The secret journey of an effective vaccine
Keeping Kenya healthy
Kuifanya Kenya kuendelea kuwa na afya
Can women be the architects of a post-pandemic Kenya?
Je Wanawake wanaweza kuwa nguzo kuu nchini Kenya, baada ya janga?
Addressing the locust crisis in East Africa: A Q&A with Dr. Christina Owen
The danger of complacency: Lost progress in vitamin A distribution
What will it take to outsmart malaria?
China's successful elimination of malaria, and its global impact
The time to adapt to climate change is now
Global action is the only way to get ahead of COVID-19
Embedding the “streetlight moments” in our mission
My commitment
One year on: Q+A reflections from CEO Mark Suzman
Remembering Bill Gates Sr., our “north star”
Measles outbreaks in an interconnected world
Melinda Gates: Why equality can’t wait
Fatimata Sy on partnering to expand access to contraceptives
How a new drug for COVID-19 could help improve treatment equity
To beat mosquitos, researchers must think like mosquitos
Why the global health community can’t afford to ignore nutrition and agriculture
Day Zero: Inside Nigeria’s response to the 2016 polio outbreak
Turning demographics into opportunity
Melinda Gates: Will the world be generous enough to defeat COVID-19?
Ending wild polio in Africa: A Q&A with Michael Galway and Violaine Mitchell
Congrats, India, you eradicated polio! What’s next?
The future of global health: polio and mobile money
Education for everyone
Primary health care takes center stage this week in Astana, Kazakhstan
A letter from our CEO, Mark Suzman: Reflections to guide our next twenty years
Helping farmers adapt to the new normal: A Q&A with Rodger Voorhies
Helping local leaders reach the most vulnerable
Closing the opportunity gap in the Sahel
The future of sanitation: 10 years of reinventing the toilet
COVID-19 vaccine dose sharing remains urgent: How do we turn pledges into doses right away?
Smallholder farming is a proven path out of poverty, but climate change is changing the rules
Sexist and incomplete data hold back the world’s COVID-19 response
Investing for Impact: A Q&A with Vidya Vasu-Devan
Leadership and continuity in a time of change: A Q&A with Mark Suzman
Amid surging demand for syringes, a new investment supports long-term supply on the African continent
They can’t Google, so they ask me about their rights
De-throning “The Throne” at the Reinvent the Toilet Expo in Beijing, China
Fighting history’s most successful infectious disease
Getting medical supplies where they’re needed most
The power of the UN General Assembly
Looking back on vaccines in 2018
Want to maintain the progress against HIV/AIDS? We need solutions for young women in sub-Saharan Africa
Two conversations with Warren
Thank you, Warren, for your generosity
We don't want to wait 99 years for gender equality
With the economic recovery failing women, now is the time to act on gender equality
Empowering Africa’s women farmers
Women on philanthropy’s front lines: A conversation with Melanie Brown and Elizabeth Barajas-Román
Banking on the future of women
Missing Perspectives: How women are left out of the news
Despite recovery efforts, women’s unemployment continues to grow
What are women’s empowerment collectives and how are they helping women weather COVID-19?
Making health systems stronger while tackling the impacts of COVID-19
What will it take to achieve COVID-19 containment and economic revival?
Innovation and sound policies are critical to protect people during the crisis
Why protecting, promoting essential services for women and children is now more critical than ever
Vaccines bring us closer to a better world
Celebrating the Second Annual World NTD Day: A Q&A with Katey Owen
Geographically distributed manufacturing capacity is needed for improved global health security
Gender Equality
COVID-19
Media Center
Annual Letters
Speeches

Home
Ideas
COVID-19

COVID-19

Perspectives on the global response to the 2019 novel coronavirus

Two health workers wearing masks and goggles pointing at an x-ray on a computer monitor — Photo by Amanuel Sileshi/AFP via Getty Images

There is no such thing as a national solution to a global crisis. All countries must work together to end the pandemic and begin rebuilding economies.

Bill Gates and Melinda French Gates

Co-chairs, Bill & Melinda Gates Foundation

This global crisis requires a shared global response: Collaboration is paramount to overcoming unprecedented challenges and consigning COVID-19 to the history books. Together, we can ensure a safe and effective vaccine is distributed equitably and affordably for every last person on earth—not just those with ability to pay. The virus does not adhere to borders, and neither can the vaccine. A global response must also aim to build more resilient health systems that protect the world’s most vulnerable and prevent future disease outbreaks.

We’re sharing the latest updates on our response to COVID-19, reflections from our leaders and partners, as well as the stories that keep us optimistic.